Results 231 to 240 of about 33,171 (260)

Polycythemia vera.

American family physician, 2004
Polycythemia vera is a chronic myeloproliferative disorder characterized by increased red blood cell mass. The resultant hyperviscosity of the blood predisposes such patients to thrombosis. Polycythemia vera should be suspected in patients with elevated hemoglobin or hematocrit levels, splenomegaly, or portal venous thrombosis.
Brian J, Stuart, Anthony J, Viera
openaire   +1 more source

Polycythemia Vera

New England Journal of Medicine, 1958
openaire   +3 more sources

Advances in Understanding and Management of Myeloproliferative Neoplasms

Ca-A Cancer Journal for Clinicians, 2009
Paola Guglielmelli
exaly  

Polycythemia Vera

JAMA: The Journal of the American Medical Association, 1990
openaire   +2 more sources

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

Cancer Cell, 2005
Jan Cools, Benjamin L Ebert, Gerlinde Wernig   +2 more
exaly  

Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

New England Journal of Medicine, 2015
Alessandro Maria Vannucchi, Martin Griesshammer, Tamas Masszi   +2 more
exaly  

Cardiovascular Events and Intensity of Treatment in Polycythemia Vera

New England Journal of Medicine, 2013
Roberto Marchioli, Giorgina Specchia, Valerio De Stefano   +2 more
exaly  

Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia

Nature Medicine, 2013
Carla Casu, Sara Gardenghi, Laura Breda
exaly  

Polycythemia (Excluding Polycythemia Vera)

2020
openaire   +1 more source

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

Nature, 2005
Chloe James, Valérie Ugo, Judith Staerk
exaly